Purchase Order 75N96018P00145
Award Date 8/23/18
Potential Completion Date 8/29/23
Potential Value $120K
Federal Agency
Awardee
Ultimate Awardee
Not listed Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Research Triangle Park, NC 27709, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases awarded a firm-fixed-price purchase order to Illumina, Inc. for a MiSeq Silver Support Plan. The contract is valued at $15,575.00 and has a completion date of March 25, 2025. Illumina, a for-profit manufacturer of genomic sequencing instruments and reagents, has previously provided sequencing systems and consumables to support research and diagnostics...
- This is a $16,198 firm fixed price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the U.S. Department of Health and Human Services, to Illumina, Inc. for a MiSeq Silver Support Plan with an ultimate completion date of February 5, 2026. Illumina is a manufacturer and provider of sequencing and array-based solutions for genetic and genomic analysis, and has been awarded previous prime contracts and subcontracts by federal...
- The Department of Health and Human Services National Institutes of Health Clinical Center awarded a firm fixed-price purchase order contract to Illumina, Inc., a manufacturer of sequencing and array-based solutions for genetic and genomic analysis. The $30,852.00 contract is for a MiSeq Gold Support Plan service agreement, with a completion date of December 12, 2024. Illumina has previously been awarded prime federal contracts by agencies such as the NIH, CDC, USDA, and VA to provide a range...
- The Department of Health and Human Services, National Institutes of Health, National Institute of Allergy and Infectious Diseases awarded a firm fixed price contract to Illumina, Inc., a for-profit manufacturer of sequencing and array-based solutions, to provide a MiSeq Silver Support Plan. The contract, which has a potential value of $15,575.00, does not have a set-aside designation and is set to be completed by February 4, 2025. Illumina has previously been awarded prime federal contracts by...
- The Department of Health and Human Services' National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a firm fixed price purchase order to Illumina, Inc., a manufacturer of sequencing and array-based solutions. The $13,250.00 contract is for a MiSeq Silver Support Plan, with a completion date of September 25, 2020. Illumina has previously received prime federal contracts from agencies like the NIH, CDC, USDA, and VA to provide a range of sequencing systems,...
- The Department of Health and Human Services National Institutes of Health National Center for Advancing Translational Sciences awarded a firm fixed price purchase order valued at ninety-nine thousand seven hundred fifty-five dollars to Illumina, Inc. to provide support services for a MiSeq Silver support plan and a NextSeq 500 Bronze support plan. The support plans are for specific Illumina sequencing instruments located in Potomac, Maryland and are required to maintain instrument subsystems and...
- This is a firm-fixed-price purchase order contract awarded by the National Heart Lung and Blood Institute (NHLBI), a component of the National Institutes of Health (NIH), to Illumina, Inc. for a MiSeq support plan. The contract has a ceiling value of $85,029.08 and a period of performance through September 11, 2029. Illumina, a manufacturer of genetic sequencing instruments and reagents, has provided a range of sequencing products and services to support research and diagnostics across various...
- The U.S. government has awarded a firm-fixed-price delivery order contract to Illumina, Inc., a manufacturer of sequencing and analysis solutions, for a MiSeq Silver Support Plan. The $14,562.64 contract, which has no set-aside designation, was awarded by the Midwest Area division of a civilian federal agency. The support plan is intended to provide maintenance and services for the MiSeq sequencing system used for laboratory equipment, consumables, and services. Illumina has previously...
- This is a firm fixed-price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency, to Illumina, Inc., a manufacturer of genetic sequencing instruments and reagents. The contract provides a MiSeq Silver Support Plan with a ceiling value of $13,250.00 and an ultimate completion date of January 2, 2021. Illumina has a long history of providing sequencing systems and related products and services to support research and diagnostics across...
- This is a $84,332.60 firm fixed price purchase order contract awarded by the Office of Acquisitions and Grants, a civilian agency, to Illumina, Inc. for a MiSeq Silver Support Plan. The contract has an ultimate completion date of August 14, 2026 and was awarded on August 15, 2020. This award does not have a set-aside designation. Illumina, a manufacturer of sequencing and array-based solutions, has previously received federal contracts and subcontracts from agencies like NIH, CDC, USDA, and VA...